DURHAM, N.C., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Humacyte, Inc. (NASDAQ:HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, today announced that Laura Niklason, M.D., Ph.D., Founder, President, and Chief Executive Officer, and Dale Sander, Chief Financial Officer, will present at the Cantor Global Healthcare Conference, in New York, NY on September 28, 2023. Management will also be available for one-on-one meetings.
Event: Cantor Global Healthcare Conference
Location: InterContinental New York Barclay Hotel, New York, NY
Formal Presentation: Thursday, September 28, 1:15-1:45 p.m. ET
Webcast: Access the live presentation here.
A ...